Treatment of colorectal cancer in the elderly: a review of the literature

dc.contributor.authorGolfinopoulos, V.en
dc.contributor.authorPentheroudakis, G.en
dc.contributor.authorPavlidis, N.en
dc.date.accessioned2015-11-24T19:07:24Z
dc.date.available2015-11-24T19:07:24Z
dc.identifier.issn0305-7372-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20432
dc.rightsDefault Licence-
dc.subjectAge Factorsen
dc.subjectAgeden
dc.subjectAntineoplastic Combined Chemotherapy Protocols/*therapeutic useen
dc.subjectChemotherapy, Adjuvanten
dc.subjectClinical Trials as Topicen
dc.subjectColorectal Neoplasms/drug therapy/surgery/*therapyen
dc.subjectComorbidityen
dc.subjectHumansen
dc.subjectMeta-Analysis as Topicen
dc.subjectPalliative Care/methodsen
dc.subjectSurvival Analysisen
dc.titleTreatment of colorectal cancer in the elderly: a review of the literatureen
heal.abstractAlthough major progress has been achieved in the treatment of colorectal cancer, there are still several questions open for discussion concerning the management of elderly colorectal cancer patients. We conducted a review of the available literature concerning the use of adjuvant chemotherapy, palliative chemotherapy and surgery in elderly patients with colorectal cancer, using data from meta-analyses, non-systematic reviews and individual trials. All report similar survival benefits with adjuvant and palliative chemotherapy in elderly patients in comparison with younger age groups. Data on treatment-related side effects did not reveal a different toxicity profile for elderly patients. Efficacy and safety data were similar but more difficult to interpret concerning surgery, so this review is inconclusive about the proper use of this treatment modality in the elderly population. It is demonstrated that there is significant gain from chemotherapy in the adjuvant and palliative management of colorectal cancer patients irrespective of age. We, therefore, conclude that all patients should receive the most intensive treatment thought to be effective and safe, according to their biological age and comorbidities.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1016/j.ctrv.2005.10.002-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16337087-
heal.identifier.secondaryhttp://www.sciencedirect.com/science/article/pii/S0305737205002100-
heal.journalNameCancer Treat Reven
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2006-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: